CD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung Cancer
Sebastian Griesing(National Taiwan University Hospital), James Chih‐Hsin Yang(National Taiwan University)
Cited by 28
Related Papers
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma
|JAMA Oncology|2017|632
Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer
|Journal of Thoracic Oncology|2019|83
Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
|PLoS ONE|2015|48
Thyroid transcription factor‐1‐regulated <i> micro <scp>RNA</scp> ‐532‐5p </i> targets <i> <scp>KRAS</scp> </i> and <i> <scp>MKL</scp> 2 </i> oncogenes and induces apoptosis in lung adenocarcinoma cells
|Cancer Science|2017|32
PD-L1 regulates c-MET phosphorylation and contributes to MET-dependent resistance to osimertinib in EGFR-mutant NSCLC
|Journal of Biomedical Science|2025|1